Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer

Autor: Gilbert, Lucy, Oaknin, Ana, Matulonis, Ursula A., Mantia-Smaldone, Gina M., Lim, Peter C., Castro, Cesar M., Provencher, Diane, Memarzadeh, Sanaz, Method, Michael, Wang, Jiuzhou, Moore, Kathleen N., O'Malley, David M.
Zdroj: In Gynecologic Oncology March 2023 170:241-247
Databáze: ScienceDirect
Externí odkaz: